NCT03453866

Brief Summary

The purpose of this study is to determine if pre-warming of arthroscopic fluid reduces immediate post-surgical pain in hip arthroscopy patients. The investigators hypothesize there will be a significant decrease in the Visual Analog Score (VAS) measured 30 minutes post-operatively in the warmed fluid group compared to the control group. Secondary outcome measures to be collected will include VAS scores 60 minutes after surgery and on post-operative day (POD) one. Additionally, the investigators will collect post-operative temperature measured 30 and 60 minutes post-operatively as well as morphine equivalent dosing in PACU and at the two-week follow up visit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 9, 2018

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 14, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 5, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2021

Completed
Last Updated

November 1, 2021

Status Verified

October 1, 2021

Enrollment Period

3.5 years

First QC Date

February 14, 2018

Last Update Submit

October 25, 2021

Conditions

Keywords

Hip ArthroscopyWarmed Fluids

Outcome Measures

Primary Outcomes (1)

  • Changes in Visual Analog Score

    A Visual Analog Score (VAS) will be measured pre-operatively, 30 and 60 minutes after patient arrival in the post-anesthesia care unit (PACU). Additionally, VAS will be collected in the clinic on post-operative day (POD) 1 and POD 14. The visual analog scale measures subject reported pain on a scale of 0-100 with a score of 0 indicating no pain and 100 indicating the worst pain possible.

    Pre-operatively, 30 and 60 minutes after completion of surgery, Post Op Days 1 and 14.

Secondary Outcomes (2)

  • Changes in Temperature

    30-60 minutes after after completion of surgery

  • Morphine Equivalent Dosage (MED)

    After completion of surgery and at the 2-week Post Operative Visit

Other Outcomes (2)

  • Hip Outcomes Score (HOS)

    Pre-operatively

  • Veterans Rand 12 (VR-12)

    Pre-Operatively

Study Arms (2)

Warmed Arthroscopic Fluids

EXPERIMENTAL

Arthroscopic Fluids will be warmed to 38 degrees Celsius during procedure with active warming device. Temperature will be measured in real time.

Procedure: Warmed Arthroscopic Fluids

Room Temperature Arthroscopic Fluids

ACTIVE COMPARATOR

Arthroscopic fluids will be kept at room temperature and will not be warmed per current standard of care. Temperature will be measured in real time.

Procedure: Room Temperature Arthroscopic Fluids

Interventions

Warmed Arthroscopic Fluids

Warmed Arthroscopic Fluids

Room Temperature Arthroscopic Fluids

Room Temperature Arthroscopic Fluids

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients aged 18-65 years with a confirmed diagnosis of Femoroacetabular impingement (FAI)
  • Required hip arthroscopy will be considered for the study
  • Pre-operative history and physical exam
  • Magnetic resonance imaging (MRI) before being indicated for arthroscopic surgery

You may not qualify if:

  • Taking narcotic medications at baseline
  • Have a history of complex regional pain syndrome,
  • Have hip arthritis,
  • Have undergone previous hip arthroscopic surgery, or
  • Are deemed incapable by the Principal Investigator of completing the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Steadman Hawkins Clinic, University of Colorado Denver

Englewood, Colorado, 80112, United States

Location

Related Publications (5)

  • Truntzer JN, Shapiro LM, Hoppe DJ, Abrams GD, Safran MR. Hip arthroscopy in the United States: an update following coding changes in 2011. J Hip Preserv Surg. 2017 Mar 23;4(3):250-257. doi: 10.1093/jhps/hnx004. eCollection 2017 Aug.

    PMID: 28948037BACKGROUND
  • Stafford GH, Malviya A, Villar RN. Fluid extravasation during hip arthroscopy. Hip Int. 2011 Nov-Dec;21(6):740-3. doi: 10.5301/HIP.2011.8845.

    PMID: 22117260BACKGROUND
  • Steelman VM, Chae S, Duff J, Anderson MJ, Zaidi A. Warming of Irrigation Fluids for Prevention of Perioperative Hypothermia During Arthroscopy: A Systematic Review and Meta-analysis. Arthroscopy. 2018 Mar;34(3):930-942.e2. doi: 10.1016/j.arthro.2017.09.024. Epub 2017 Dec 6.

    PMID: 29217304BACKGROUND
  • Ousey K, Edward KL, Lui S, Stephenson J, Walker K, Duff J, Leaper D. Perioperative, local and systemic warming in surgical site infection: a systematic review and meta-analysis. J Wound Care. 2017 Nov 2;26(11):614-624. doi: 10.12968/jowc.2017.26.11.614.

    PMID: 29131754BACKGROUND
  • Benson EE, McMillan DE, Ong B. The effects of active warming on patient temperature and pain after total knee arthroplasty. Am J Nurs. 2012 May;112(5):26-33; quiz 34, 42. doi: 10.1097/01.NAJ.0000414315.41460.bf.

    PMID: 22546733BACKGROUND

MeSH Terms

Conditions

Femoracetabular ImpingementPain, Postoperative

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative ComplicationsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • James Genuario, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Sealed Opaque Envelope
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2018

First Posted

March 5, 2018

Study Start

February 9, 2018

Primary Completion

August 1, 2021

Study Completion

September 20, 2021

Last Updated

November 1, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations